8/8/12 – The U.S. Department of Health and Human Services recently announced that Medicare prescription premiums will remain constant in 2013. This marks the third straight year where prescription drug premiums for will not increase. Medicaid recipients have also saved $3.9 billion on prescription drugs since the Affordable Care Act took effect.
8/7/12 – Yesterday, Gov. Cuomo submitted to the Center for Medicaid Services the much-anticipated MRT Medicaid waiver amendment that, if approved, will allow the state to reinvest Medicaid savings into new programs that are designed to reap more savings in the years to come.
8/2/12 – Starting today, New York Health Works will begin serving up our weekly summary of health care news called “Weekly Dose of Health News” on our blog.
8/2/12 – Governor Cuomo revealed a pilot program yesterday that will allow colleges to offer health insurance directly to students in New York.
8/1/12 – The children of a late mother and nurse honor her today with the establishment a fund that financially assists struggling students trying to obtain their nursing degree.
07/25/12 – A new report, Research in Your Backyard: Developing Cures, Creating Jobs, examines the impact pharmaceutical clinical trials has on patients and the economy of New York.
6/14/12 – Eli Lilly recently unveiled an application for mobile devices that will make it easier for doctors to access information about clinical trials for cancer drugs.
6/13/12 – Representatives from New York Health Works and Partnership for Prescription Assistance (PPA) attended two events in the New York City area this past weekend.
5/29/12 – Even though the 2012-13 budget was finalized at the end of March, both the NYS Assembly and Senate are still fighting for patient access in Medicaid. Each house has taken different approaches to allow prescribers to have the final say on patients’ drug regimens and to standardize the prior authorization process.
5/21/12 – The New York Times ran an editorial today about a new research program announced by Pres. Obama that will test a drug’s ability to prevent the onset of Alzheimer’s disease before any symptoms appear. The trial does not adhere to conventional guidelines but instead focuses on members of an extended family in Colombia who carry a rare genetic mutation that causes them to develop Alzheimer’s in their 40’s.